Skip to main content

Market Overview

Mid-Morning Market Update: Markets Mixed; Paychex Profit Beats Views

Share:

Following the market opening Wednesday, the Dow traded up 0.75% to 20860.00 while the NASDAQ fell 0.93% to 7348.99. The S&P also fell, dropping 0.44% to 2436.60.

US reported a total of 55,200 coronavirus cases with around 800 deaths. Italy reported a total of at least 69,100 confirmed cases and 6,800 deaths, while Spain confirmed a total of over 42,000 coronavirus cases. Mainland China reported 47 new cases on Tuesday. In total, there are at least 428,400 cases of COVID-19 worldwide with over 19,100 deaths.

Leading and Lagging Sectors

Industrial shares climbed 1% on Wednesday. Meanwhile, top gainers in the sector included Nesco Holdings, Inc. (NYSE: NSCO), up 18%, and Spirit Airlines, Inc. (NYSE: SAVE), up 16%.

In trading on Wednesday, communication services shares fell 2.5%.

Top Headline

Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected earnings for its third quarter, while sales missed views.

Paychex reported quarterly earnings of $0.97 per share, beating analysts’ estimates of $0.96 per share. Revenue came in at $1.12 billion, slightly missing the consensus expectations of $1.14 billion.

 

Equities Trading UP

Astrotech Corporation (NASDAQ: ASTC) shares shot up 593% to $7.69 after the company announced it is developing its BreathTest 1000 screening instrument for lung diseases including Coronavirus and Pneumonia.

Shares of T2 Biosystems, Inc. (NASDAQ: TTOO) got a boost, shooting 140% to $0.9342 after the company announced a worldwide licensing agreement to support the development of a rapid COVID-19 test developed by Hackensack Meridian Health.

PennyMac Mortgage Investment Trust (NYSE: PMT) shares were also up, gaining 42% to $8.15.

Equities Trading DOWN

IMAC Holdings, Inc. (NASDAQ: IMAC) shares tumbled 47% to $2.62 after surging more than 1000% on Tuesday.

Shares of Immutep Limited (NASDAQ: IMMP) were down 68% to $0.59 after the company announced data from the Phase 2b AIPAC study that evaluated its lead product candidate eftilagimod alpha in combination with paclitaxel, a taxane standard-of-care chemotherapy, in HER2-negative/HR+ metastatic breast cancer, which showed 63% of patients treated with the combo were progression-free at the 6-month landmark.

Exantas Capital Corp. (NASDAQ: XAN) was down, falling 40% to $1.68. Exantas Capital issued an update on status of financing arrangements as of March 25, 2020.

Commodities

In commodity news, oil traded down 2.2% to $23.48, while gold traded down 1.2% to $1,641.40.

Silver traded up 1.1% Wednesday to $14.41, while copper fell 0.8% to $2.1625.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 rose 0.3% the Spanish Ibex Index slipped 0.1%, while Italy’s FTSE MIB Index fell 0.1%. Meanwhile, the German DAX dropped 1.3%, and the French CAC 40 rose 0.4% while UK shares rose 1.1%.

Economics

US durable goods orders rose 1.2% for February, versus economists’ expectations for a 0.8% decline.

The FHFA house price index rose 0.3% for January, versus a revised 0.7% gain in December.

The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is scheduled for release at 10:30 a.m. ET.

The business expectations and uncertainty indexes for March will be released at 11:00 a.m. ET.

The Treasury is set to auction 5-year notes at 1:00 p.m. ET.

 

Related Articles (ASTC + IMAC)

View Comments and Join the Discussion!

Posted-In: Mid-Morning Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com